机译:Is metabolic‐dysfunction‐associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo‐responsiveness among patients with end‐stage kidney disease on haemodialysis?
机译:A retrospective database analysis of erythropoiesis‐stimulating agent treatment patterns and associated healthcare resource use in patients with non–dialysis‐dependent chronic kidney disease–related anaemia in Japan